Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
-
* Corresponding author: Jeremy Chancellor jeremy.chancellor@i3innovus.com
BMC Neurology 2009, 9:6 doi:10.1186/1471-2377-9-6
Clarification of study codes
Edward Whitney (2010-12-23 18:19) Colorado Division of Workers Compensation
Some clarification is needed. The pregabalin studies are referred to not by author but by a code. I am in possession of Rosenstock et al (reference #15), and I notice that it enrolled 76 patients on pregabalin 100 mg tid, with 70 patients on placebo. I infer that this is “DPN-131,” though I find this code nowhere in the Rosenstock article, nor do I find a key to the code on the website.
Can this be clarified?
Competing interests
None declared
top